Complex Generic Sponsors Not Using US FDA-EMA Parallel Scientific Advice Program

 
• By Derrick Gingery
US and EU collaboration
FDA officials believe the FDA-EMA parallel scientific advice program could be beneficial for complex generic sponsors. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics